<DOC>
	<DOCNO>NCT00234299</DOCNO>
	<brief_summary>Aspirin affect many physiological process anti-inflammatory action . Various cancer , include prostate cancer , appear utilize inflammatory signal facilitate growth progression . We hypothesize oral aspirin act directly prostate epithelial cell alter COX-2-related metabolism inhibit prostate cell growth .</brief_summary>
	<brief_title>Effects ASA Prostate Tissue</brief_title>
	<detailed_description>Prostate cancer common non-cutaneous malignancy men second lead cause cancer death among U.S. men . 221,000 new case 29,000 death expect 2003 . The incidence prostate cancer diagnosis increase 3 % per year . Prostate specific antigen ( PSA ) screening result improvement early diagnosis prostate cancer . However , available treatment may significant negative effect quality life . Studies implicate beneficial association ASA use low risk type malignancy , include stomach , esophageal , breast , ovarian , prostate cancer . There significant evidence suggest aspirin protective effect prostate cancer .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<criteria>May watchful wait low grade prostate cancer schedule biopsy monitor disease . Have previous diagnosis prostatic intraepithelial neoplasia ( PIN ) atypical small acinar proliferation ( ASAP ) either second biopsy even second biopsy still PIN ASAP undergo third biopsy . Extendedsector ( least 10 core ) prostate biopsy perform within three month enrollment . Prostate tissue frozen time prostate biopsy ( UW # 043963V 01 ) PSA le 15 . Performance status 0 1 ECOG scale . Ability understand willingness sign inform consent document . Willingness take 325mg enteric coat aspirin daily abstain NSAID , aspirin product , COX2 inhibitor study . Willingness abstain hormonal herbal preparation indicate affect hormone level study . Any prior concurrent hormonal therapy , chemotherapy , investigational agent . Use Finasteride , Dutasteride , saw palmetto , herbal/nutritional preparation indicate affect hormone level . Use 325mg aspirin three time week . Use NSAIDS three time week . Use NSAIDs , Cox2 inhibitor and/or aspirin 6 week prior study enrollment 3month intervention . Known bleed disorder . History gastrointestinal bleeding . History peptic duodenal ulcer disease . History stroke . History serious bleeding , include limited hemorrhagic stroke , epistaxis , hematuria , hematochezia , hemorrhoidal bleed require cauterization . Uncontrolled hypertension . Aspirin sensitivity allergy . Liver disease know ascites , varix , clot disorder , liver function test &gt; 1.5 normal . Anemia , thrombocytopenia , prolong INR . Elective surgery schedule 3month intervention . Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , CHD presently require revascularization procedure , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Prostate</keyword>
	<keyword>Preventive Therapy</keyword>
</DOC>